SBC Medical Group Holdings Incorporated (NASDAQ: SBC) announced the completion of a secondary public offering of 3.1 million shares of common stock at $3.25 per share. The shares were sold by Dr. Yoshiyuki Aikawa, a selling stockholder, who received approximately $10.1 million in proceeds before deducting underwriting fees.

The company did not sell any shares in the offering and received no proceeds from the transaction. Maxim Group LLC served as sole book-running manager while Roth Capital Partners acted as co-manager for the offering.

The offering was conducted under the company's effective shelf registration statement on Form S-3 filed with the Securities and Exchange Commission. A final prospectus supplement describing the offering terms has been filed with the SEC.

SBC Medical operates as a management services organization with franchise businesses across medical fields including aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, and ophthalmology. The company manages clinic brands and operates in the United States and Asia through direct operations and medical tourism initiatives.